Inventor

DUNCIA JOHN V

US54 patents

⚠️ This page may combine multiple inventors who share the name “DUNCIA JOHN V”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DUNCIA JOHN V

BRISTOL MYERS SQUIBB CO

Cyclic derivatives as modulators of chemokine receptor activity

Cyclic derivatives as modulators of chemokine receptor activity

Piperidinyl derivatives as modulators of chemokine receptor activity

Heteroaryl substituted aminopyridine compounds

Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity

Cyclic derivatives as modulators of chemokine receptor activity

Bicyclic and tricyclic amines as modulators of chemokine receptor activity

Phosphine oxide alkyl amide substituted heteroaryl compounds as modulators of IL-12, IL-23 and/or IFN alpha responses

N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-2-oxo-3-(6-(trifluoromethyl)quinazolin-4-ylamino) pyrrolidin-1-yl)cyclohexyl)acetamide and other modulators of chemokine receptor activity, crystalline forms and process

Cyclic derivatives as modulators of chemokine receptor activity

Heteroaryl substituted aminopyridine compounds

Heteroaryl substituted pyridyl compounds useful as kinase modulators

Bicyclic heterocycle substituted pyridyl compounds useful as kinase modulators

Heteroaryl substituted nicotinamide compounds

Piperidinyl derivatives as modulators of chemokine receptor activity

Substituted thienopyrroles as PAD4 inhibitors

Substituted imidazo[1,2-b]pyridazines as interleukin-23 and interferon-α modulators

Heteroaryl substituted pyridyl compounds useful as kinase modulators

Spirocyclic compounds as modulators of chemokine receptor activity

Cyclic derivatives as modulators of chemokine receptor activity

Bicyclic and tricyclic amines as modulators of chemokine receptor activity

N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity

N-ureidoalkyl-piperidines as modulators of chemokine receptor activity

Heteroaryl substituted pyridyl compounds useful as kinase modulators

BRISTOL MYERS SQUIBB PHARMA CO

N-ureidoalkyl-piperidines as modulators of chemokine receptor activity

Heterocyclic piperidines as modulators of chemokine receptor activity

Piperidine amides as modulators of chemokine receptor activity

N-ureidoalkyl-piperidines as modulators of chemokine receptor activity

N-ureidoalkyl-piperidines as modulators of chemokine receptor activity

2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity

N-ureidoalkyl-piperidines as modulators of chemokine receptor activity

Benzylcycloalkyl amines as modulators of chemokine receptor activity

N-ureidoalkyl-piperidines as modulators of chemokine receptor activity

N-ureidoalkyl-piperidines as modulators of chemokine receptor activity

Benzylcycloalkyl amines as modulators of chemokine receptor activity

Piperidine amides as modulators of chemokine receptor activity

Bicyclic and tricyclic amines as modulators of chemokine receptor activity

Bicyclic and tricyclic amines as modulators of chemokine receptor activity

2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity

N-ureidoalkyl-piperidines as modulators of chemokine receptor activity

N-ureidoalkyl-piperidines as modulators of chemokine receptor activity

N-ureidoalkyl-piperidines as modulators of chemokine receptor activity

Heterocyclic piperidines as modulators of chemokine receptor activity

(unassigned)

N-ureidoalkyl-piperidines as modulators of chemokine receptor activity

Heterocycyclic piperidines as modulators of chemokine receptor activity

BRSITOL MYERS SQUIBB PHARMA CO

N-ureidoalkyl-piperidines as modulators of chemokine receptor activity

BRISTOL MYERS SQUIBB PHARMA

Benzylcycloalkyl amines as modulators of chemokine receptor activity

CHERNEY ROBERT J

Piperidinyl compound as a modulator of chemokine receptor activity

GARDNER DANIEL S

Piperidinyl derivatives as modulators of chemokine receptor activity

DHAR T G MURALI

Spirocyclic compounds as modulators of chemokine receptor activity